Friday, January 10, 2020 4:02:43 PM
They will getting this mythical IND
In one form or another.
Submit for a Phase 2b - it gets rejected.
Plan to submit a Phase 1 as a follow up. Should be extremely easy to do. But Kenny will find a way to say it's sooooo complicated. Good enuff for another yr.
Then having boxed himself into a corner, Kenny is forced to submit a Phase 1 IND. Which should get accepted. SHs rejoice. Then nothing happens. Takes forever for Kenny to post a record in the ClinTrials database. Despite pronounced speculation, no patients show up. For months... years?
Aah, but having escaped the box, Kenny then starts PR pumping the ascites nonsense. While waiting for the mythical patient to show up, Kenny gets to recycle pre-clinical PR pumps - oops forgot the pre-IND meeting. Years more of entertainment.
playing for another year and another year and another year after that
In one form or another.
Submit for a Phase 2b - it gets rejected.
Plan to submit a Phase 1 as a follow up. Should be extremely easy to do. But Kenny will find a way to say it's sooooo complicated. Good enuff for another yr.
Then having boxed himself into a corner, Kenny is forced to submit a Phase 1 IND. Which should get accepted. SHs rejoice. Then nothing happens. Takes forever for Kenny to post a record in the ClinTrials database. Despite pronounced speculation, no patients show up. For months... years?
Aah, but having escaped the box, Kenny then starts PR pumping the ascites nonsense. While waiting for the mythical patient to show up, Kenny gets to recycle pre-clinical PR pumps - oops forgot the pre-IND meeting. Years more of entertainment.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:17:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:16:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:19:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/17/2026 07:49:54 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/09/2026 01:40:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 10:02:46 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 10:05:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/07/2026 10:43:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/18/2025 10:04:23 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 12/15/2025 09:00:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2025 10:07:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2025 10:00:25 PM
- PharmaCyte Biotech stock surges following profitable exit from Femasys investment • IH Market News • 11/25/2025 03:56:47 PM
- PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment • Business Wire • 11/25/2025 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2025 09:32:29 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/18/2025 09:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:33 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/06/2025 09:08:43 PM
